Celltrion, Inc. (068270.KS)
KRW 193100.0
(-3.06%)
KRW 193100.0
(-3.06%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 19917.53 Billion KRW | 238.06% |
| 2022 | 5891.65 Billion KRW | 3.83% |
| 2021 | 5674.12 Billion KRW | 13.03% |
| 2020 | 5020.12 Billion KRW | 30.07% |
| 2019 | 3859.64 Billion KRW | 10.18% |
| 2018 | 3503.1 Billion KRW | 6.35% |
| 2017 | 3294.09 Billion KRW | 9.01% |
| 2016 | 3021.94 Billion KRW | 9.96% |
| 2015 | 2748.23 Billion KRW | 18.34% |
| 2014 | 2322.38 Billion KRW | 17.38% |
| 2013 | 1978.5 Billion KRW | 14.17% |
| 2012 | 1732.91 Billion KRW | 23.14% |
| 2011 | 1407.31 Billion KRW | 21.8% |
| 2010 | 1155.46 Billion KRW | 106.63% |
| 2009 | 559.2 Billion KRW | 12.01% |
| 2008 | 499.26 Billion KRW | 712.34% |
| 2007 | 61.46 Billion KRW | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 20153.11 Billion KRW | 1.18% |
| 2024 Q2 | 20127.05 Billion KRW | -0.13% |
| 2023 Q2 | 6287.88 Billion KRW | 2.63% |
| 2023 Q3 | 6555.08 Billion KRW | 4.25% |
| 2023 Q1 | 6126.91 Billion KRW | 3.99% |
| 2023 Q4 | 19917.53 Billion KRW | 203.85% |
| 2023 FY | 19917.53 Billion KRW | 238.06% |
| 2022 Q3 | 5901.34 Billion KRW | 3.75% |
| 2022 Q4 | 5891.65 Billion KRW | -0.16% |
| 2022 Q2 | 5687.91 Billion KRW | 0.88% |
| 2022 FY | 5891.65 Billion KRW | 3.83% |
| 2022 Q1 | 5638.19 Billion KRW | -0.63% |
| 2021 Q3 | 5535.55 Billion KRW | 5.29% |
| 2021 Q4 | 5674.12 Billion KRW | 2.5% |
| 2021 Q1 | 5211.38 Billion KRW | 3.81% |
| 2021 Q2 | 5257.33 Billion KRW | 0.88% |
| 2021 FY | 5674.12 Billion KRW | 13.03% |
| 2020 FY | 5020.12 Billion KRW | 30.07% |
| 2020 Q2 | 4349.74 Billion KRW | 5.47% |
| 2020 Q1 | 4124.01 Billion KRW | 6.85% |
| 2020 Q4 | 5020.12 Billion KRW | 8.23% |
| 2020 Q3 | 4638.29 Billion KRW | 6.63% |
| 2019 Q3 | 3790.81 Billion KRW | 2.9% |
| 2019 Q2 | 3684.04 Billion KRW | 5.18% |
| 2019 FY | 3859.64 Billion KRW | 10.18% |
| 2019 Q1 | 3502.49 Billion KRW | -0.02% |
| 2019 Q4 | 3859.64 Billion KRW | 1.82% |
| 2018 Q1 | 3523.22 Billion KRW | 6.96% |
| 2018 Q4 | 3503.1 Billion KRW | 1.13% |
| 2018 Q3 | 3464.13 Billion KRW | -2.96% |
| 2018 FY | 3503.1 Billion KRW | 6.35% |
| 2018 Q2 | 3569.81 Billion KRW | 1.32% |
| 2017 FY | 3294.09 Billion KRW | 9.01% |
| 2017 Q2 | 3162.7 Billion KRW | 2.98% |
| 2017 Q3 | 3289.06 Billion KRW | 4.0% |
| 2017 Q4 | 3294.09 Billion KRW | 0.15% |
| 2017 Q1 | 3071.18 Billion KRW | 1.63% |
| 2016 Q3 | 2919.02 Billion KRW | 2.21% |
| 2016 Q4 | 3021.94 Billion KRW | 3.53% |
| 2016 Q1 | 2735.22 Billion KRW | -0.47% |
| 2016 FY | 3021.94 Billion KRW | 9.96% |
| 2016 Q2 | 2855.82 Billion KRW | 4.41% |
| 2015 Q4 | 2748.23 Billion KRW | 2.32% |
| 2015 Q3 | 2685.98 Billion KRW | 4.08% |
| 2015 FY | 2748.23 Billion KRW | 18.34% |
| 2015 Q2 | 2580.61 Billion KRW | 7.77% |
| 2015 Q1 | 2394.55 Billion KRW | 3.11% |
| 2014 Q3 | 2302.49 Billion KRW | 1.81% |
| 2014 Q2 | 2261.46 Billion KRW | 4.0% |
| 2014 FY | 2322.38 Billion KRW | 17.38% |
| 2014 Q4 | 2322.38 Billion KRW | 0.86% |
| 2014 Q1 | 2174.44 Billion KRW | 9.9% |
| 2013 FY | 1978.5 Billion KRW | 14.17% |
| 2013 Q4 | 1978.5 Billion KRW | -1.34% |
| 2013 Q3 | 2005.33 Billion KRW | 1.36% |
| 2013 Q2 | 1978.33 Billion KRW | -6.03% |
| 2013 Q1 | 2105.18 Billion KRW | 21.48% |
| 2012 Q4 | 1732.91 Billion KRW | 0.0% |
| 2012 Q1 | 1488.24 Billion KRW | 0.0% |
| 2012 FY | 1732.91 Billion KRW | 23.14% |
| 2011 Q1 | 1202.37 Billion KRW | 4.06% |
| 2011 FY | 1407.31 Billion KRW | 21.8% |
| 2011 Q3 | 1380.58 Billion KRW | 9.64% |
| 2011 Q2 | 1259.22 Billion KRW | 4.73% |
| 2010 Q1 | 583.89 Billion KRW | 4.42% |
| 2010 Q4 | 1155.46 Billion KRW | 5.23% |
| 2010 FY | 1155.46 Billion KRW | 106.63% |
| 2010 Q3 | 1098.05 Billion KRW | 6.93% |
| 2010 Q2 | 1026.85 Billion KRW | 75.86% |
| 2009 Q3 | 525.91 Billion KRW | 2.42% |
| 2009 Q2 | 513.48 Billion KRW | -3.85% |
| 2009 Q1 | 534.06 Billion KRW | 6.97% |
| 2009 FY | 559.2 Billion KRW | 12.01% |
| 2009 Q4 | 559.2 Billion KRW | 6.33% |
| 2008 Q3 | 527.92 Billion KRW | 897.62% |
| 2008 Q1 | 50.96 Billion KRW | 0.0% |
| 2008 FY | 499.26 Billion KRW | 712.34% |
| 2008 Q2 | 52.91 Billion KRW | 3.83% |
| 2008 Q4 | 499.26 Billion KRW | -5.43% |
| 2007 Q3 | 48.56 Billion KRW | 1.14% |
| 2007 Q1 | 41.8 Billion KRW | 0.0% |
| 2007 Q2 | 48.01 Billion KRW | 14.85% |
| 2007 FY | 61.46 Billion KRW | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| ORIENT BIO Inc. | 96.98 Billion KRW | -20436.126% |
| Green Cross Holdings Corporation | 3737.7 Billion KRW | -432.881% |
| Green Cross Holdings Corporation | 2643.31 Billion KRW | -653.506% |
| Pharmicell Co., Ltd. | 99.19 Billion KRW | -19979.923% |
| Green Cross Corporation | 2643.31 Billion KRW | -653.506% |
| GeneOne Life Science, Inc. | 151 Billion KRW | -13089.747% |
| Samsung Biologics Co.,Ltd. | 16046.19 Billion KRW | -24.126% |
| SK bioscience Co.,Ltd. | 1852.43 Billion KRW | -975.206% |
| SK Biopharmaceuticals Co., Ltd. | 723.17 Billion KRW | -2654.196% |
| Prestige BioPharma Limited | 711.72 Billion KRW | -2698.505% |